Concepts (130)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, N-Methyl-D-Aspartate | 11 | 2020 | 266 | 1.940 |
Why?
|
| Plasmodium falciparum | 4 | 2015 | 45 | 0.990 |
Why?
|
| Spermidine Synthase | 2 | 2015 | 3 | 0.790 |
Why?
|
| Machine Learning | 2 | 2019 | 170 | 0.730 |
Why?
|
| Antimalarials | 3 | 2015 | 71 | 0.690 |
Why?
|
| Models, Biological | 2 | 2019 | 981 | 0.520 |
Why?
|
| Allosteric Regulation | 6 | 2020 | 58 | 0.500 |
Why?
|
| Drug Discovery | 4 | 2019 | 94 | 0.440 |
Why?
|
| Algorithms | 1 | 2019 | 1196 | 0.440 |
Why?
|
| Enzyme Inhibitors | 1 | 2015 | 659 | 0.390 |
Why?
|
| Piperidines | 1 | 2012 | 123 | 0.390 |
Why?
|
| Molecular Dynamics Simulation | 4 | 2017 | 109 | 0.370 |
Why?
|
| Xenopus laevis | 5 | 2020 | 60 | 0.350 |
Why?
|
| Models, Molecular | 6 | 2020 | 546 | 0.280 |
Why?
|
| Excitatory Amino Acid Antagonists | 2 | 2020 | 128 | 0.260 |
Why?
|
| Binding Sites | 4 | 2020 | 631 | 0.260 |
Why?
|
| Ion Channel Gating | 2 | 2020 | 42 | 0.260 |
Why?
|
| Protein Binding | 4 | 2020 | 1027 | 0.250 |
Why?
|
| Ligands | 2 | 2017 | 317 | 0.230 |
Why?
|
| Computer Simulation | 2 | 2010 | 706 | 0.230 |
Why?
|
| Reproducibility of Results | 2 | 2019 | 2077 | 0.220 |
Why?
|
| Oxidoreductases Acting on CH-NH Group Donors | 1 | 2022 | 39 | 0.210 |
Why?
|
| Spermine | 1 | 2022 | 49 | 0.210 |
Why?
|
| NAD | 1 | 2022 | 73 | 0.200 |
Why?
|
| Patch-Clamp Techniques | 3 | 2017 | 204 | 0.190 |
Why?
|
| Viral Fusion Proteins | 1 | 2020 | 4 | 0.180 |
Why?
|
| Respiratory Syncytial Virus, Human | 1 | 2020 | 11 | 0.180 |
Why?
|
| Bayes Theorem | 2 | 2019 | 307 | 0.180 |
Why?
|
| Databases, Nucleic Acid | 1 | 2019 | 15 | 0.170 |
Why?
|
| Nucleic Acids | 1 | 2019 | 16 | 0.170 |
Why?
|
| Mutation, Missense | 2 | 2017 | 112 | 0.170 |
Why?
|
| Synaptic Transmission | 1 | 2020 | 236 | 0.170 |
Why?
|
| Benzimidazoles | 1 | 2020 | 128 | 0.170 |
Why?
|
| Small Molecule Libraries | 1 | 2019 | 53 | 0.160 |
Why?
|
| HIV Reverse Transcriptase | 1 | 2018 | 4 | 0.160 |
Why?
|
| Workflow | 1 | 2019 | 100 | 0.160 |
Why?
|
| Drug Resistance, Viral | 1 | 2018 | 14 | 0.160 |
Why?
|
| Reverse Transcriptase Inhibitors | 1 | 2018 | 28 | 0.160 |
Why?
|
| Nerve Tissue Proteins | 1 | 2020 | 290 | 0.160 |
Why?
|
| Molecular Targeted Therapy | 1 | 2019 | 170 | 0.150 |
Why?
|
| ROC Curve | 1 | 2019 | 392 | 0.150 |
Why?
|
| Point Mutation | 1 | 2018 | 97 | 0.150 |
Why?
|
| Liver Neoplasms | 1 | 2022 | 334 | 0.150 |
Why?
|
| Animals | 9 | 2020 | 20881 | 0.150 |
Why?
|
| Antiviral Agents | 1 | 2020 | 211 | 0.150 |
Why?
|
| Excitatory Amino Acid Agents | 1 | 2017 | 20 | 0.150 |
Why?
|
| Proton Magnetic Resonance Spectroscopy | 1 | 2017 | 27 | 0.150 |
Why?
|
| Stereoisomerism | 1 | 2017 | 169 | 0.150 |
Why?
|
| Tetrahydroisoquinolines | 1 | 2017 | 4 | 0.150 |
Why?
|
| Protein Conformation | 1 | 2017 | 362 | 0.140 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2017 | 346 | 0.140 |
Why?
|
| Developmental Disabilities | 1 | 2017 | 119 | 0.130 |
Why?
|
| Epilepsy | 2 | 2017 | 336 | 0.130 |
Why?
|
| Glutamic Acid | 3 | 2016 | 332 | 0.130 |
Why?
|
| Biomarkers, Tumor | 1 | 2019 | 508 | 0.130 |
Why?
|
| Structure-Activity Relationship | 4 | 2020 | 420 | 0.130 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2015 | 73 | 0.120 |
Why?
|
| Pyruvate Dehydrogenase Complex | 1 | 2013 | 9 | 0.110 |
Why?
|
| Data Mining | 1 | 2013 | 45 | 0.110 |
Why?
|
| HEK293 Cells | 3 | 2020 | 326 | 0.100 |
Why?
|
| Protein Interaction Mapping | 1 | 2012 | 62 | 0.100 |
Why?
|
| Antineoplastic Agents | 1 | 2019 | 1070 | 0.100 |
Why?
|
| Computational Biology | 1 | 2013 | 190 | 0.100 |
Why?
|
| Quinolones | 1 | 2011 | 60 | 0.090 |
Why?
|
| Humans | 13 | 2022 | 68618 | 0.090 |
Why?
|
| Pyrazoles | 1 | 2011 | 190 | 0.090 |
Why?
|
| Rats | 3 | 2014 | 5300 | 0.090 |
Why?
|
| Antibiotics, Antitubercular | 1 | 2010 | 18 | 0.090 |
Why?
|
| Cycloserine | 1 | 2010 | 30 | 0.090 |
Why?
|
| Membrane Potentials | 1 | 2010 | 200 | 0.090 |
Why?
|
| Protein Domains | 2 | 2020 | 74 | 0.080 |
Why?
|
| Protein Subunits | 2 | 2020 | 99 | 0.080 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2020 | 1745 | 0.080 |
Why?
|
| Peptide Initiation Factors | 1 | 2006 | 11 | 0.070 |
Why?
|
| Motion | 1 | 2006 | 24 | 0.070 |
Why?
|
| Protozoan Proteins | 1 | 2006 | 25 | 0.070 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2006 | 204 | 0.070 |
Why?
|
| Amino Acid Sequence | 2 | 2020 | 1083 | 0.070 |
Why?
|
| Mice | 2 | 2020 | 8474 | 0.060 |
Why?
|
| RNA-Binding Proteins | 1 | 2006 | 215 | 0.060 |
Why?
|
| Cell Line | 2 | 2020 | 1752 | 0.060 |
Why?
|
| Flavins | 1 | 2022 | 5 | 0.050 |
Why?
|
| Acrolein | 1 | 2022 | 9 | 0.050 |
Why?
|
| Spermidine | 1 | 2022 | 21 | 0.050 |
Why?
|
| Cell Proliferation | 1 | 2006 | 1174 | 0.050 |
Why?
|
| Polyamines | 1 | 2022 | 79 | 0.050 |
Why?
|
| Glycine | 2 | 2014 | 89 | 0.050 |
Why?
|
| Voltage-Dependent Anion Channels | 1 | 2022 | 40 | 0.050 |
Why?
|
| Hydrogen Peroxide | 1 | 2022 | 168 | 0.050 |
Why?
|
| Molecular Docking Simulation | 1 | 2022 | 78 | 0.050 |
Why?
|
| Adenosine Triphosphate | 1 | 2022 | 314 | 0.050 |
Why?
|
| Mice, 129 Strain | 1 | 2020 | 44 | 0.040 |
Why?
|
| Xenopus | 1 | 2020 | 30 | 0.040 |
Why?
|
| Excitatory Amino Acid Agonists | 1 | 2020 | 59 | 0.040 |
Why?
|
| Protein Structure, Secondary | 1 | 2020 | 136 | 0.040 |
Why?
|
| Organ Culture Techniques | 1 | 2020 | 122 | 0.040 |
Why?
|
| Amino Acids | 1 | 2020 | 131 | 0.040 |
Why?
|
| Nucleic Acid Conformation | 1 | 2019 | 92 | 0.040 |
Why?
|
| Microsomes, Liver | 1 | 2017 | 44 | 0.040 |
Why?
|
| Female | 3 | 2020 | 38074 | 0.040 |
Why?
|
| Mitochondria | 1 | 2022 | 643 | 0.040 |
Why?
|
| Conserved Sequence | 1 | 2017 | 67 | 0.040 |
Why?
|
| Mutant Proteins | 1 | 2017 | 45 | 0.040 |
Why?
|
| Crystallography, X-Ray | 1 | 2017 | 190 | 0.040 |
Why?
|
| Exome | 1 | 2016 | 20 | 0.040 |
Why?
|
| HIV-1 | 1 | 2018 | 177 | 0.040 |
Why?
|
| Hippocampus | 1 | 2020 | 471 | 0.040 |
Why?
|
| Administration, Oral | 1 | 2017 | 411 | 0.030 |
Why?
|
| Molecular Structure | 1 | 2017 | 397 | 0.030 |
Why?
|
| Protein Transport | 1 | 2016 | 280 | 0.030 |
Why?
|
| Intellectual Disability | 1 | 2016 | 114 | 0.030 |
Why?
|
| Seizures | 1 | 2016 | 279 | 0.030 |
Why?
|
| Synapses | 1 | 2017 | 222 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2020 | 2791 | 0.030 |
Why?
|
| Sugar Phosphates | 1 | 2013 | 2 | 0.030 |
Why?
|
| Substrate Specificity | 1 | 2013 | 234 | 0.030 |
Why?
|
| Hydroxamic Acids | 1 | 2013 | 84 | 0.030 |
Why?
|
| Cricetinae | 1 | 2011 | 262 | 0.020 |
Why?
|
| DNA, Complementary | 1 | 2011 | 251 | 0.020 |
Why?
|
| Neurons | 1 | 2016 | 881 | 0.020 |
Why?
|
| HIV Infections | 1 | 2018 | 791 | 0.020 |
Why?
|
| Biophysics | 1 | 2010 | 41 | 0.020 |
Why?
|
| Mutagenesis | 1 | 2010 | 60 | 0.020 |
Why?
|
| Cell Line, Transformed | 1 | 2010 | 100 | 0.020 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2010 | 57 | 0.020 |
Why?
|
| Microinjections | 1 | 2010 | 130 | 0.020 |
Why?
|
| Oocytes | 1 | 2010 | 57 | 0.020 |
Why?
|
| Electric Stimulation | 1 | 2010 | 218 | 0.020 |
Why?
|
| Time Factors | 1 | 2017 | 4655 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2011 | 2673 | 0.020 |
Why?
|